Clinical Trials Logo

Esotropia clinical trials

View clinical trials related to Esotropia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06221098 Completed - Infantile Esotropia Clinical Trials

Study of Clinical Types and Treatment Outcomes of Pediatric Esotropia in Sohag University Hospital

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Strabismus (or squint) is defined as the presence of misalignment between the visual axes of the 2 eyes presenting with deviation of the eyes. Strabismus is further subdivided into comitant (if the amount of misalignment between the 2 eyes remained equal in all directions of gaze) and incomitant (if the amount of misalignment varied in different directions of gaze). If the squinting eye was deviated inward, it is termed as a convergent squint or esotropia and if the squinting eye is deviated outward, it is termed as a divergent squint or exotropia. Pediatric esotropia may be congenital or acquired. Congenital esotropia is a well-defined entity with an onset prior to 6 months of age, characterised by a large stable angle, cross fixation, and a limited potential for binocular single vision. Acquired childhood esotropia may be paralytic or non-paralytic. The non-paralytic or concomitant type, which is neither congenital nor secondary to ocular pathology, can be divided into three main groups: (1) Accommodative esotropia, which may be fully accommodative, partially accommodative, or accommodative with convergence excess; (2) Non-accommodative esotropia; (3) Esotropia associated with neurological dysfunction, in particular cerebral palsy and hydrocephalus. The last group of esotropia will be excluded from our study. Pediatric strabismus must be treated early to maximize the potential for binocular vision and decrease the risk of amblyopia. Treatment goals include good vision in each eye (no amblyopia) and straight eyes (orthotropia). Both conditions are necessary to produce stereopsis, which is a third goal. Strabismus in children may result in undesirable appearance, amblyopia, impaired stereopsis, diplopia, and negative psychological effect.

NCT ID: NCT05786053 Completed - V Pattern Esotropia Clinical Trials

Correction of V-pattern Strabismus by Graded Recession of Inferior Oblique Muscle .

Pattern
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

V pattern strabismus is the commonest of alphabet pattern. Its identification is essential to plan a proper surgical management. Graded recession is a very logical approach to treat inferior oblique overaction (IOOA). The aim Is to evaluate the efficacy of graded recession of inferior oblique muscle for correction of different grades of V pattern.

NCT ID: NCT04429659 Completed - Refractive Errors Clinical Trials

Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia

Start date: January 2, 2019
Phase:
Study type: Observational

To investigate changes in refractive errors and evaluate clinical outcomes of strabismus surgery in patients with both amblyopia and partially refractive esotropia (PAET).Amblyopic patients with PAET were enrolled. Non-amblyopic patients with full refractive accommodative esotropia (RAET) were included in the study as a control group. Preoperative and postoperative best corrected visual acuity (BCVA), spherical equivalent (SE), astigmatism, stereoacuity and deviations at near and distance were evaluated and statistically compared in the patient group. The mean BCVA, SE, astigmatism were compared between the patient and the control groups.

NCT ID: NCT03459092 Completed - Acquired Esotropia Clinical Trials

Botox Instead of Strabismus Surgery (BISS)

BISS
Start date: August 16, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate if strabismus can be successfully treated requiring less surgical interventions with a Botox-based treatment regimen compared to a purely surgery based treatment regimen. Experimental arm: Botulinum toxin injection in the horizontal extraocular muscles. Control (active comparator) arm: Strabismus surgery on the horizontal extraocular muscles. No investigational product is used. In Switzerland the standard procedure for treating large angle esotropia is surgery, which is performed on the horizontal eye muscles that may be either recessed or shortened leading to reduced or increased muscle function respectively. As an alternative to strabismus surgery, botulinum toxin (Botox) can be applied in extraocular muscles. Botox prevents the release of acetylcholine in the synaptic cleft and thereby blocks the neuromuscular transmission thus inducing a palsy. Current evidence on the use of Botox in strabismus is incoherent, is poorly supported by basic research findings and leaves dedicated clinicians in the dark. The objective is to shed light into this field of clinical research, which may help to guide future pediatric ophthalmologists in their management of strabismic patients. In a best case scenario, the results from this trial will prevent strabismus operation for many children with acquired large angle esotropia.

NCT ID: NCT02570555 Completed - Strabismus Clinical Trials

Strabismus Surgery and Driving Ability

Start date: November 2013
Phase:
Study type: Observational

The strabismus impacts binocular visual acuity and stereoscopy. Thus, driving capacities of patients with strabismus may be reduced. The goal of this work is to study the possible amelioration of driving ability after strabismus surgery and to compare the driving capacities of patients with strabismus to a normal population; Patients will be tested before and after strabismus surgery using a driving simulator, binocular visual field and binocular visual acuity.

NCT ID: NCT02413463 Completed - Clinical trials for Partially Accommodative Esotropia

Augmented Medial Rectus Muscle Recession Versus Posterior Scleral Fixation in Partially Accommodative Esotropia

Start date: January 2015
Phase: N/A
Study type: Interventional

Prospective randomized interventional comparative study

NCT ID: NCT01460355 Completed - Exotropia Clinical Trials

Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone

Start date: September 2006
Phase: Phase 4
Study type: Interventional

Two different treatments were given to large angle horizontal strabismus (eso and exotropia) adult patients who agree to participate of the study. Inform consents were required for participants. Group 1 (12 patients) received conventional recess-resect surgery plus intraoperative injection of botulinum toxin A (5U). Group 2 (11 patients) received only conventional recess-resect surgery. The patients were randomly located in one of the groups. The angles of horizontal deviation were compared between the groups before and six months after treatment.

NCT ID: NCT01179711 Completed - Clinical trials for Accommodative Esotropia

Under-correction in Refractive Accommodative Esotropia

Start date: June 2009
Phase: N/A
Study type: Interventional

In most clinics, physicians reduce diopter of hyperopic glasses in older patients with accommodative esotropia. However, there are risks of decompensation in that practice. The authors are going to try measure the change of stability of eye alignment after reducing diopter of hyperopic glasses.

NCT ID: NCT01166503 Completed - Esotropia Clinical Trials

Early Versus Delayed Surgery for Infantile Esotropia

Start date: May 2004
Phase:
Study type: Observational

The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy).

NCT ID: NCT00746304 Completed - Esotropia Clinical Trials

Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin

Start date: September 2007
Phase: N/A
Study type: Observational

To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.